- March 1, 2016
- Posted by: emobile
- Category: Researcher's Corner
Emobileclinic Researchers’ corner
Female sexual desire or urge are controlled by numbers of factors and women know better when they want sex which is only understood by them and invariably by the moves they make. Men don’t have this grace as the penis will tell if a man is in deed sexually aroused or not. A drug was produced last year to help women who don’t desire sex always to over come this. Hypoactive sexual desire disorder affects a lot of women and the drug received massive attention and patronage due to this.
The very first week in the market Flibanserine popularly known as Addyi was reported to have sold 227 batches. In less than a year of its existence, Flibanserine appears to have caused more harms than benefits as reported in a recent research which studied the effect of the drugs on over 5000 women who used it. ” US Food and Drug Administration (FDA) approved flibanserin as a treatment for hypoactive sexual desire disorder (HSDD) in premenopausal women, despite concern about suboptimal risk-benefit trade-offs ” says the author of the new study published in JAMA Internal Medicine.